Business Standard

Friday, December 27, 2024 | 12:11 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Iran, Russia discussing joint production of Covid-19 vaccine: Report

The Russian Direct Investment Fund has said it is in talks with a number of countries about the possibility of producing the Russian 'Sputnik-V' vaccine abroad

covid, coronavirus, vaccine, drug, pharma

It has signed deals with Kazakhstan and two states in Brazil, and private pharmaceutical firms in India and Mexico.

Reuters MOSCOW

MOSCOW (Reuters) - Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday.

"We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying.

Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

 

 

(Reporting by Anton Kolodyazhnyy; Writing by Polina Ivanova; Editing by Toby Chopra)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 25 2020 | 3:51 PM IST

Explore News